Ajami; Alfred M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ajami; Alfred M..The latest application filed is for "indazole compounds for treating inflammatory disorders, demyelinating disorders and cancers".

Company Profile

0.12.10

Ajami; Alfred M. - Brookline MA
Ajami; Alfred M. - Boston MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Indazole Compounds for Treating Inflammatory Disorders, Demyelinating Disorders and Cancers App 20100292231 - Ajami; Alfred M. ; et al.	2010-11-18
Method Of Treating Multidrug Resistant Cancers App 20100204263 - Ajami; Alfred M. ; et al.	2010-08-12
Imidazoacridine Compounds for Treating FLT3-Mediated Disorders App 20100016300 - Ajami; Alfred M.	2010-01-21
Compounds for treating inflammatory disorders, demyelinating disdorders and cancers App 20080108641 - Ajami; Alfred M.	2008-05-08
Compounds for treating autoimmune and demyelinating diseases App 20060189546 - Ajami; Alfred M. ; et al.	2006-08-24
Amonafide salts Grant 6,989,390 - Ajami , et al. January 24, 2	2006-01-24
Amonafide salts App 20050239816 - Ajami, Alfred M. ; et al.	2005-10-27
Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion App 20050059738 - Ajami, Alfred M. ; et al.	2005-03-17
Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion Grant 6,846,842 - Ajami , et al. January 25, 2	2005-01-25
Amonafide salts App 20040132763 - Ajami, Alfred M. ; et al.	2004-07-08
Assessment of gastric emptying disorders Grant 6,740,305 - Ajami May 25, 2	2004-05-25
Amonafide salts Grant 6,693,198 - Ajami , et al. February 17, 2	2004-02-17
Amonafide salts App 20030203932 - Ajami, Alfred M. ; et al.	2003-10-30
In vivo determination of metabolic function for use in therapy management Grant 6,610,270 - Ajami August 26, 2	2003-08-26
Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion App 20030073743 - Ajami, Alfred M. ; et al.	2003-04-17
In vivo determination of metabolic function for use in therapy management Grant 6,284,219 - Ajami September 4, 2	2001-09-04
Electrochemical dehalogenation of organic compounds Grant 4,775,450 - Ajami * October 4, 1	1988-10-04
Electrochemical dehalogenation of organic compounds Grant 4,707,230 - Ajami November 17, 1	1987-11-17
Halogen complexing homotetra-alkyl salts for use in halogen cells Grant 4,147,840 - Walsh , et al. April 3, 1	1979-04-03
Two phase electrolytes used as halogen traps in metal halogen secondary cells and batteries Grant 4,065,601 - Ajami , et al. December 27, 1	1977-12-27
Halogen complexing ethers Grant 4,038,460 - Walsh , et al. July 26, 1	1977-07-26
Halogen complexing alcohols and nitriles Grant 4,038,459 - Ajami , et al. July 26, 1	1977-07-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.